{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:40:28Z","timestamp":1776238828966,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fonds voor Innovatie en Klinisch Onderzoek","award":["FIKO21\/TYPE2\/007"],"award-info":[{"award-number":["FIKO21\/TYPE2\/007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00520-026-10595-0","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:03:52Z","timestamp":1775120632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-treatment audiological and vestibular assessment in adults starting platinum-based chemotherapy"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-3950","authenticated-orcid":false,"given":"Heleen","family":"Van Der Biest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-7719","authenticated-orcid":false,"given":"Sarah","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-9448","authenticated-orcid":false,"given":"Hannah","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-5512","authenticated-orcid":false,"given":"Leen","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-4260","authenticated-orcid":false,"given":"Frederic","family":"Acke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1508-7263","authenticated-orcid":false,"given":"Eline","family":"Naert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2060-3725","authenticated-orcid":false,"given":"Sylvie","family":"Rottey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-1079","authenticated-orcid":false,"given":"Ingeborg","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"10595_CR1","unstructured":"Roland PS, Rutka JA (2004) Ototoxicity.\u00a0BC Decker, Hamilton"},{"issue":"8","key":"10595_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/bjc.1998.226","volume":"77","author":"C Bokemeyer","year":"1998","unstructured":"Bokemeyer C et al (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77(8):1355\u20131362","journal-title":"Br J Cancer"},{"issue":"23","key":"10595_CR3","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","volume":"34","author":"RD Frisina","year":"2016","unstructured":"Frisina RD et al (2016) Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol 34(23):2712\u20132720","journal-title":"J Clin Oncol"},{"key":"10595_CR4","doi-asserted-by":"publisher","first-page":"102203","DOI":"10.1016\/j.canep.2022.102203","volume":"79","author":"LK Dillard","year":"2022","unstructured":"Dillard LK et al (2022) Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis. Cancer Epidemiol 79:102203","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10595_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1288\/00005537-199404000-00016","volume":"104","author":"M Wake","year":"1994","unstructured":"Wake M et al (1994) Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope 104(4):488\u2013493","journal-title":"Laryngoscope"},{"issue":"45","key":"10595_CR6","doi-asserted-by":"publisher","first-page":"14077","DOI":"10.1523\/JNEUROSCI.2845-09.2009","volume":"29","author":"SG Kujawa","year":"2009","unstructured":"Kujawa SG, Liberman MC (2009) Adding insult to injury: cochlear nerve degeneration after \u201ctemporary\u201d noise-induced hearing loss. J Neurosci 29(45):14077\u201314085","journal-title":"J Neurosci"},{"issue":"2","key":"10595_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00280-019-04012-z","volume":"85","author":"DM Baguley","year":"2020","unstructured":"Baguley DM, Prayuenyong P (2020) Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemother Pharmacol 85(2):245\u2013250","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"10595_CR8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jamaoncol.2024.1233","volume":"10","author":"VA Sanchez","year":"2024","unstructured":"Sanchez VA et al (2024) Comprehensive audiologic analyses after cisplatin-based chemotherapy. JAMA Oncol 10(7):912\u2013922","journal-title":"JAMA Oncol"},{"issue":"sup4","key":"10595_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1080\/14992027.2017.1398421","volume":"57","author":"D Konrad-Martin","year":"2018","unstructured":"Konrad-Martin D et al (2018) Applying US national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. Int J Audiol 57(sup4):S3\u2013S18","journal-title":"Int J Audiol"},{"key":"10595_CR10","doi-asserted-by":"publisher","unstructured":"Van Der Biest H et al (2025) Early markers of sensorineural hearing loss after platinum-based chemotherapy. Ear and Hearing. https:\/\/doi.org\/10.1097\/AUD.0000000000001714","DOI":"10.1097\/AUD.0000000000001714"},{"key":"10595_CR11","unstructured":"Durrant JD,\u00a0Campbell K, Fausti S, Guthrie O, Jacobson G, Lonsbury-Martin BL, Poling G (2009) American academy of audiology position statement and clinical practice guidelines: ototoxicity monitoring.\u00a0http:\/\/www.audiology.org\/resources\/documentlibrary\/Documents\/OtoMonGuidelines"},{"key":"10595_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fonc.2018.00363","volume":"8","author":"P Prayuenyong","year":"2018","unstructured":"Prayuenyong P et al (2018) Vestibulotoxicity associated with platinum-based chemotherapy in survivors of cancer: a scoping review. Front Oncol 8:363","journal-title":"Front Oncol"},{"issue":"sup4","key":"10595_CR13","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1080\/14992027.2018.1468092","volume":"57","author":"JA Handelsman","year":"2018","unstructured":"Handelsman JA (2018) Vestibulotoxicity: strategies for clinical diagnosis and rehabilitation. Int J Audiol 57(sup4):S69\u2013S77","journal-title":"Int J Audiol"},{"key":"10595_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00415-015-7903-4","volume":"263","author":"M Lacour","year":"2016","unstructured":"Lacour M et al (2016) Vestibular compensation: the neuro-otologist\u2019s best friend. J Neurol 263:54\u201364","journal-title":"J Neurol"},{"key":"10595_CR15","doi-asserted-by":"publisher","first-page":"1437468","DOI":"10.3389\/fsurg.2024.1437468","volume":"11","author":"T Fleihan","year":"2024","unstructured":"Fleihan T et al (2024) Cisplatin vestibulotoxicity: a current review. Front Surg 11:1437468","journal-title":"Front Surg"},{"issue":"6","key":"10595_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0145561320949482","volume":"101","author":"R H\u00fclse","year":"2022","unstructured":"H\u00fclse R et al (2022) Changes in vestibular function in patients with head-and-neck cancer undergoing chemoradiation. Ear Nose Throat J 101(6):379\u2013385","journal-title":"Ear Nose Throat J"},{"issue":"6","key":"10595_CR17","doi-asserted-by":"publisher","first-page":"NP337","DOI":"10.1177\/01455613221115042","volume":"104","author":"K Ehlert","year":"2025","unstructured":"Ehlert K et al (2025) Changes in vestibular and cochlear function following platinum-based chemotherapy: a preliminary report. Ear, Nose Throat J 104(6):NP337\u2013NP348","journal-title":"Ear, Nose Throat J"},{"key":"10595_CR18","doi-asserted-by":"publisher","first-page":"695268","DOI":"10.3389\/fnins.2021.695268","volume":"15","author":"P Prayuenyong","year":"2021","unstructured":"Prayuenyong P et al (2021) Preferential cochleotoxicity of cisplatin. Front Neurosci 15:695268","journal-title":"Front Neurosci"},{"key":"10595_CR19","doi-asserted-by":"crossref","unstructured":"Takada N, Okuda H, Shibata H, Obara N, Mori K, Terazawa K\u00a0et al (2025) Quantitative assessment of vestibular function by video head impulse test and vestibular\u2010evoked myogenic potential during cisplatin\u2010based Chemoradiation. Clin Otolaryngol\u00a050(5):883\u2013889","DOI":"10.1111\/coa.14335"},{"issue":"9","key":"10595_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamaoto.2015.1515","volume":"141","author":"EA Theunissen","year":"2015","unstructured":"Theunissen EA et al (2015) Prediction of hearing loss due to cisplatin chemoradiotherapy. JAMA Otolaryngol-Head Neck Surg 141(9):810\u2013815","journal-title":"JAMA Otolaryngol-Head Neck Surg"},{"key":"10595_CR21","unstructured":"American Speech-Language-Hearing Association (1994)\u00a0Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy.\u00a0ASHA\u00a036 (Suppl 12):11\u20139"},{"key":"10595_CR22","doi-asserted-by":"crossref","unstructured":"Fernandez K,\u00a0Hoetink A, Konrad-Martin D, Berndtson D, Clark K, Dreisbach L, Geller JI, Goffi -Gomez MV, Grosnik A, Jamis C\u00a0et al (2024) Roadmap to a global template for implementation of ototoxicity management for cancer treatment. Ear Hear\u00a046:286\u2013297","DOI":"10.1097\/AUD.0000000000001592"},{"issue":"6","key":"10595_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1044\/persp2.SIG6.17","volume":"2","author":"L Dreisbach","year":"2017","unstructured":"Dreisbach L et al (2017) Effects of oxaliplatin, carboplatin, and cisplatin across treatment on high-frequency objective and subjective auditory measures in adults. Perspect ASHA Spec Interest Groups 2(6):17\u201338","journal-title":"Perspect ASHA Spec Interest Groups"},{"key":"10595_CR24","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.heares.2020.108132","volume":"400","author":"V Vasilkov","year":"2021","unstructured":"Vasilkov V et al (2021) Enhancing the sensitivity of the envelope-following response for cochlear synaptopathy screening in humans: the role of stimulus envelope. Hear Res 400:108132","journal-title":"Hear Res"},{"issue":"7","key":"10595_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/14992027.2023.2215943","volume":"63","author":"N Portugal","year":"2024","unstructured":"Portugal N, Poling GL, Dreisbach L (2024) Rethinking the clinical utility of distortion-product otoacoustic emission (DPOAE) signal-to-noise ratio. Int J Audiol 63(7):491\u2013499","journal-title":"Int J Audiol"},{"issue":"2","key":"10595_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000490050","volume":"70","author":"M Coene","year":"2018","unstructured":"Coene M et al (2018) LiCoS: A new linguistically controlled sentences test to assess functional hearing performance. Folia Phoniatr Logop 70(2):90\u201399","journal-title":"Folia Phoniatr Logop"},{"key":"10595_CR27","unstructured":"Keshishzadeh S, Verhulst S (2019) From derived-band envelope-following responses to individualized models of near-and supra-threshold hearing deficits. In: International Symposium on Auditory and Audiological Research, vol 7 (Nyborg), pp 13\u201320"},{"issue":"1","key":"10595_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1121\/10.0016807","volume":"153","author":"H Van Der Biest","year":"2023","unstructured":"Van Der Biest H et al (2023) Envelope following responses for hearing diagnosis: robustness and methodological considerations. J Acoust Soc Am 153(1):191\u2013208","journal-title":"J Acoust Soc Am"},{"key":"10595_CR29","first-page":"1","volume":"260","author":"D De Ridder","year":"2021","unstructured":"De Ridder D et al (2021) Tinnitus and tinnitus disorder: theoretical and operational definitions (an international multidisciplinary proposal). Prog Brain Res 260:1\u201325","journal-title":"Prog Brain Res"},{"key":"10595_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.heares.2016.05.009","volume":"337","author":"A McCormack","year":"2016","unstructured":"McCormack A et al (2016) A systematic review of the reporting of tinnitus prevalence and severity. Hear Res 337:70\u201379","journal-title":"Hear Res"},{"issue":"1","key":"10595_CR31","doi-asserted-by":"publisher","first-page":"e70097","DOI":"10.1002\/oto2.70097","volume":"9","author":"JI Basheer","year":"2025","unstructured":"Basheer JI et al (2025) Impact of cisplatin on hearing: analysis using PTA, high-frequency audiometry, DPOAE, and speech-in-noise test. OTO Open 9(1):e70097","journal-title":"OTO Open"},{"issue":"10","key":"10595_CR32","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","volume":"25","author":"KR Knight","year":"2007","unstructured":"Knight KR et al (2007) Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 25(10):1190\u20131195","journal-title":"J Clin Oncol"},{"issue":"3","key":"10595_CR33","first-page":"158","volume":"20","author":"G Laurell","year":"1991","unstructured":"Laurell G, Bagger-Sj\u00f6b\u00e4ck D (1991) Dose-dependent inner ear changes after iv administration of cisplatin. J Otolaryngol 20(3):158\u2013167","journal-title":"J Otolaryngol"},{"key":"10595_CR34","doi-asserted-by":"crossref","unstructured":"Zuur CL et al (2007) Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol* Biology* Physics. 68(5): p. 1320\u20131325","DOI":"10.1016\/j.ijrobp.2007.01.042"},{"issue":"9","key":"10595_CR35","doi-asserted-by":"publisher","first-page":"E515","DOI":"10.1002\/lary.28543","volume":"130","author":"J Skalleberg","year":"2020","unstructured":"Skalleberg J et al (2020) The relationship between cisplatin-related and age-related hearing loss during an extended follow-up. Laryngoscope 130(9):E515\u2013E521","journal-title":"Laryngoscope"},{"issue":"3","key":"10595_CR36","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1002\/cam4.5218","volume":"12","author":"M Shahbazi","year":"2023","unstructured":"Shahbazi M et al (2023) Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer. Cancer Med 12(3):2999\u20133012","journal-title":"Cancer Med"},{"issue":"4","key":"10595_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/0284186X.2021.1887514","volume":"60","author":"J Skalleberg","year":"2021","unstructured":"Skalleberg J et al (2021) Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity? Acta Oncol 60(4):426\u2013433","journal-title":"Acta Oncol"},{"issue":"3","key":"10595_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clinph.2009.11.003","volume":"121","author":"H Keppler","year":"2010","unstructured":"Keppler H et al (2010) The effects of aging on evoked otoacoustic emissions and efferent suppression of transient evoked otoacoustic emissions. Clin Neurophysiol 121(3):359\u2013365","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10595_CR39","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1121\/1.401009","volume":"89","author":"BL Lonsbury-Martin","year":"1991","unstructured":"Lonsbury-Martin BL, Cutler WM, Martin GK (1991) Evidence for the influence of aging on distortion-product otoacoustic emissions in humans. J Acoust Soc Am 89(4):1749\u20131759","journal-title":"J Acoust Soc Am"},{"issue":"04","key":"10595_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3766\/jaaa.19.4.5","volume":"19","author":"LE Dreisbach","year":"2008","unstructured":"Dreisbach LE et al (2008) Influence of ultrahigh-frequency hearing thresholds on distortion-product otoacoustic emission levels at conventional frequencies. J Am Acad Audiol 19(04):325\u2013336","journal-title":"J Am Acad Audiol"},{"issue":"6","key":"10595_CR41","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1121\/1.1904403","volume":"117","author":"D Konrad-Martin","year":"2005","unstructured":"Konrad-Martin D, Keefe DH (2005) Transient-evoked stimulus-frequency and distortion-product otoacoustic emissions in normal and impaired ears. J Acoust Soc Am 117(6):3799\u20133815","journal-title":"J Acoust Soc Am"},{"issue":"1","key":"10595_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/AUD.0b013e3181e8b6a7","volume":"32","author":"KM Reavis","year":"2011","unstructured":"Reavis KM et al (2011) Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear 32(1):61\u201374","journal-title":"Ear Hear"},{"issue":"1","key":"10595_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1121\/1.2204437","volume":"120","author":"JA Lapsley Miller","year":"2006","unstructured":"Lapsley Miller JA et al (2006) Low-level otoacoustic emissions may predict susceptibility to noise-induced hearing loss. J Acoust Soc Am 120(1):280\u2013296","journal-title":"J Acoust Soc Am"},{"key":"10595_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2018.07.053","volume":"407","author":"P Wu","year":"2019","unstructured":"Wu P et al (2019) Primary neural degeneration in the human cochlea: evidence for hidden hearing loss in the aging ear. Neuroscience 407:8\u201320","journal-title":"Neuroscience"},{"issue":"3","key":"10595_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/010503999424707","volume":"28","author":"AD Lauretis","year":"1999","unstructured":"Lauretis AD et al (1999) ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scand Audiol 28(3):139\u2013143","journal-title":"Scand Audiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10595-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:40:51Z","timestamp":1776235251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10595-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10595"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10595-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Ghent University Hospital (ONZ-2022\u20130419), adhered to the Declaration of Helsinki, and obtained written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}